Ten years of publicly funded biological disease‐modifying antirheumatic drugs in Australia
Article in The Medical Journal of Australia (February 2016)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Identifying stakeholder opinion regarding access to “high-cost medicines”: A systematic review of the literature
Article in Open Medicine (June 2014)
Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries
Article in Health Policy (November 2011)